Skip to main content
. 2019 Dec 9;3(23):4043–4049. doi: 10.1182/bloodadvances.2019000930

Table 2.

Patterns of antifungal prophylaxis

None Micafungin Azole P
AML setting .0714
 Newly diagnosed (n = 55) 18 (33) 24 (44) 13 (24)
 r/r (n = 64) 7 (11) 25 (39) 32 (50)
Patient age, y .0426
 ≤65 (n = 41) 5 (12) 13 (32) 23 (56)
 >65 (n = 78) 20 (26) 32 (41) 26 (33)
HMA type and schedule .5194
 Decitabine
  5 d (n = 49) 11 (22) 21 (43) 17 (35)
  10 d (n = 54) 9 (17) 20 (37) 25 (46)
 Azacitidine (n = 16) 5 (31) 4 (25) 7 (44)

Data are n (%).